Table 2.
Characteristics of patients underwent gastroscopy in the medium–high risk of GC groups
| Characteristics | Overall (%) |
|---|---|
| Overall | 1019 (100) |
| Age | |
| 40–49 | 9 (0.89) |
| 50–59 | 631 (61.92) |
| 60–69 | 271 (26.59) |
| > 69 | 108 (10.6) |
| Sex | |
| Female | 166 (16.29) |
| Male | 853 (83.71) |
| Hp | |
| Negative | 522 (51.23) |
| Positive | 497 (48.77) |
| PGR | |
| < 3.89 | 110 (10.79) |
| ≥ 3.89 | 909 (89.21) |
| G-17 | |
| ≤ 1.50 | 7 (0.69) |
| 1.50–5.70 | 494 (48.48) |
| > 5.70 | 518 (50.83) |
| Risk level | |
| Moderate risk group | 919 (90.19) |
| High risk group | 100 (9.91) |
| Gastroscopy result | |
| Chronic superficial gastritis | 388 (38.08) |
| Erosive gastritis | 267 (26.2) |
| Non-neoplastic polyps | 79 (7.75) |
| Gastric ulcer | 109 (10.7) |
| Atrophic gastritis | 52 (5.1) |
| Intestinal-type gastritis | 69 (6.77) |
| LGIN | 25 (2.45) |
| Gastric stromal tumor | 3 (0.29) |
| Early cancer | 12 (1.18) |
| Advanced cancer | 15 (1.47) |
GC gastric cancer, Hp Helicobacter pylori, PGR pepsinogen ratio, G-17 gastrin-17, LGIN low-grade intraepithelial neoplasia